Cerebral Endothelial Cells in Neurodegeneration

📖 Wiki Page

cell793 wordssynced 2026-04-02

Cerebral Endothelial Cells

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Cerebral Endothelial Cells in Neurodegeneration</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Lining of cerebral blood vessels (capillaries, arterioles, venules)</td>
</tr>
<tr>
<td class="label">Marker Genes</td>
<td>CLDN5 (claudin-5), OCLN (occludin), TJP1 (ZO-1), SLC2A1 (GLUT1)</td>
</tr>
<tr>
<td class="label">Developmental Origin</td>
<td>Neuroectoderm (angioblasts)</td>
</tr>
<tr>
<td class="label">Key Functions</td>
<td>BBB formation, selective transport, neurovascular coupling</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:1001602](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_1001602)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:1001602](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_1001602)</td>
</tr>
</table>

Introduction

Cerebral Endothelial Cells In Neurodegeneration is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

...

Cerebral Endothelial Cells

Introduction

Cerebral endothelial cells (CECs) form the structural foundation of the blood-brain barrier (BBB), creating a highly specialized interface between the peripheral circulation and the central nervous system. [@zlokovic2008]

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

PanglaoDB Marker Cross-References

Unknown (PanglaoDB):

External Database Links

[Cell Ontology (CL:1001602)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_1001602)
[OBO Foundry (CL:1001602)](http://purl.obolibrary.org/obo/CL_1001602)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
[PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

Unknown (PanglaoDB):

External Database Links

[Cell Ontology (CL:1001602)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_1001602)
[OBO Foundry (CL:1001602)](http://purl.obolibrary.org/obo/CL_1001602)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[PanglaoDB](https://panglaodb.se/)

Anatomy and Specialization

Cerebral endothelial cells differ dramatically from peripheral endothelial cells:

Structural Features

Tight junctions: Extremely tight intercellular junctions with high expression of claudin-5, occludin, and ZO-1
Reduced pinocytosis: Limited transcytosis compared to peripheral endothelium
High mitochondrial density: Supports active transport functions
Uniform luminal surface: Lacks fenestrations in most brain regions

Transport Properties

Cerebral endothelial express specific transporters for:

Glucose: GLUT1 (SLC2A1) for glucose entry
Amino acids: System L, y+ transporters
Ion channels: Na+/K+ ATPase, various channels
Efflux transporters: P-glycoprotein (ABCB1), BCRP (ABCG2)

Normal Physiological Functions

Blood-Brain Barrier Function

The BBB restricts passage of:

Large molecules: >400 Da typically excluded
Charged molecules: Anionic molecules particularly restricted
Most drugs: Efflux pumps actively remove many therapeutics

This protection comes at the cost of limited drug delivery to the brain.

Neurovascular Coupling

Cerebral endothelial cells:

Detect neural activity signals
Release vasodilators (NO, prostaglandins) in response
Coordinate with pericytes and smooth muscle cells
Adjust blood flow to meet metabolic demands

Angiogenesis

During development and repair, endothelial cells:

Proliferate and migrate to form new vessels
Respond to VEGF and other angiogenic signals
Establish new BBB characteristics

Role in Neurodegenerative Diseases

Alzheimer's Disease

Cerebral endothelial dysfunction in AD:

BBB breakdown: Increased permeability allows peripheral proteins into brain
Amyloid clearance impairment: Reduced Aβ efflux via P-gp and LRP1
Endothelial cell loss: Reduced capillary density observed in AD brains
Oxidative stress: Endothelial mitochondria show increased ROS
Cerebral amyloid angiopathy: Aβ deposition in vessel walls

Parkinson's Disease

Endothelial changes in PD:

BBB permeability: Increased leak in substantia nigra
α-Synuclein transport: Possible spread via endothelial transcytosis
Endothelial nitric oxide synthase (eNOS) dysfunction: Altered vasodilation

Amyotrophic Lateral Sclerosis

BBB disruption: Observed in both patients and animal models
Capillary loss: Reduced vascular density in motor cortex
Endothelial degeneration: ultrastructural abnormalities

Multiple Sclerosis

BBB breakdown: Central to lesion formation
Immune cell trafficking: Activated T-cells cross the BBB
Endothelial repair defects: Impaired recovery

Stroke and Vascular Dementia

Primary injury: Ischemic damage to endothelial cells
Reperfusion injury: Oxidative stress on endothelium
Chronic dysfunction: Contributes to vascular cognitive impairment

Therapeutic Implications

Drug Delivery Strategies

Transient BBB opening: Hyperosmolar mannitol, bradykinin analogs

Nanoparticle delivery: Engineered particles that cross the BBB

Inhibition of efflux pumps: P-gp inhibitors (currently limited by toxicity)

Intranasal delivery: Bypasses BBB via olfactory route

Endothelial-Targeted Therapies

VEGF inhibitors: For excessive angiogenesis
NO donors: To improve cerebral blood flow
Antioxidants: To protect endothelial function

Background

The study of Cerebral Endothelial Cells In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

[Alzheimer's Disease](/diseases/alzheimers-disease)
[Amyloid Hypothesis](/mechanisms/amyloid-hypothesis)
[Tau Pathology](/mechanisms/tau-pathology)
[Parkinson's Disease](/diseases/parkinsons-disease)
[α-Synuclein](/proteins/alpha-synuclein)

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Cross-References

[Blood-Brain Barrier](/mechanisms/blood-brain-barrier) Neurovascular Unit
Pericytes
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lat- [Amyloid-beta](/proteins/amyloid-beta))
P-glycoprotein
[Amyloid-beta](/proteins/amyloid-beta)

📖 View canonical wiki page →